Table of Content

1 Market Overview of HIV Vaccines
1.1 HIV Vaccines Market Overview
1.1.1 HIV Vaccines Product Scope
1.1.2 HIV Vaccines Market Status and Outlook
1.2 Global HIV Vaccines Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global HIV Vaccines Market Size by Region (2024-2034)
1.4 Global HIV Vaccines Historic Market Size by Region (2024-2024)
1.5 Global HIV Vaccines Market Size Forecast by Region (2024-2034)
1.6 Key Regions, HIV Vaccines Market Size (2024-2034)
1.6.1 North America HIV Vaccines Market Size (2024-2034)
1.6.2 Europe HIV Vaccines Market Size (2024-2034)
1.6.3 Asia-Pacific HIV Vaccines Market Size (2024-2034)
1.6.4 Latin America HIV Vaccines Market Size (2024-2034)
1.6.5 Middle East & Africa HIV Vaccines Market Size (2024-2034)
2 HIV Vaccines Market by Type
2.1 Introduction
2.1.1 Phase I
2.1.2 Phase II
2.1.3 Phase III
2.2 Global HIV Vaccines Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global HIV Vaccines Historic Market Size by Type (2024-2024)
2.2.2 Global HIV Vaccines Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America HIV Vaccines Revenue Breakdown by Type (2024-2034)
2.3.2 Europe HIV Vaccines Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific HIV Vaccines Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America HIV Vaccines Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa HIV Vaccines Revenue Breakdown by Type (2024-2034)
3 HIV Vaccines Market Overview by Application
3.1 Introduction
3.1.1 Research Institute
3.1.2 Others
3.2 Global HIV Vaccines Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global HIV Vaccines Historic Market Size by Application (2024-2024)
3.2.2 Global HIV Vaccines Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America HIV Vaccines Revenue Breakdown by Application (2024-2034)
3.3.2 Europe HIV Vaccines Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific HIV Vaccines Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America HIV Vaccines Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa HIV Vaccines Revenue Breakdown by Application (2024-2034)
4 HIV Vaccines Competition Analysis by Players
4.1 Global HIV Vaccines Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HIV Vaccines as of 2022)
4.3 Date of Key Players Enter into HIV Vaccines Market
4.4 Global Top Players HIV Vaccines Headquarters and Area Served
4.5 Key Players HIV Vaccines Product Solution and Service
4.6 Competitive Status
4.6.1 HIV Vaccines Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Argos Therapeutics
5.1.1 Argos Therapeutics Profile
5.1.2 Argos Therapeutics Main Business
5.1.3 Argos Therapeutics HIV Vaccines Products, Services and Solutions
5.1.4 Argos Therapeutics HIV Vaccines Revenue (US$ Million) & (2024-2024)
5.1.5 Argos Therapeutics Recent Developments
5.2 Bionor Pharma
5.2.1 Bionor Pharma Profile
5.2.2 Bionor Pharma Main Business
5.2.3 Bionor Pharma HIV Vaccines Products, Services and Solutions
5.2.4 Bionor Pharma HIV Vaccines Revenue (US$ Million) & (2024-2024)
5.2.5 Bionor Pharma Recent Developments
5.3 Janssen Global Services
5.3.1 Janssen Global Services Profile
5.3.2 Janssen Global Services Main Business
5.3.3 Janssen Global Services HIV Vaccines Products, Services and Solutions
5.3.4 Janssen Global Services HIV Vaccines Revenue (US$ Million) & (2024-2024)
5.3.5 Genecure Recent Developments
5.4 Genecure
5.4.1 Genecure Profile
5.4.2 Genecure Main Business
5.4.3 Genecure HIV Vaccines Products, Services and Solutions
5.4.4 Genecure HIV Vaccines Revenue (US$ Million) & (2024-2024)
5.4.5 Genecure Recent Developments
5.5 Geovax
5.5.1 Geovax Profile
5.5.2 Geovax Main Business
5.5.3 Geovax HIV Vaccines Products, Services and Solutions
5.5.4 Geovax HIV Vaccines Revenue (US$ Million) & (2024-2024)
5.5.5 Geovax Recent Developments
5.6 Paxvax
5.6.1 Paxvax Profile
5.6.2 Paxvax Main Business
5.6.3 Paxvax HIV Vaccines Products, Services and Solutions
5.6.4 Paxvax HIV Vaccines Revenue (US$ Million) & (2024-2024)
5.6.5 Paxvax Recent Developments
5.7 Inovio Pharmaceuticals
5.7.1 Inovio Pharmaceuticals Profile
5.7.2 Inovio Pharmaceuticals Main Business
5.7.3 Inovio Pharmaceuticals HIV Vaccines Products, Services and Solutions
5.7.4 Inovio Pharmaceuticals HIV Vaccines Revenue (US$ Million) & (2024-2024)
5.7.5 Inovio Pharmaceuticals Recent Developments
5.8 Glaxosmithkline
5.8.1 Glaxosmithkline Profile
5.8.2 Glaxosmithkline Main Business
5.8.3 Glaxosmithkline HIV Vaccines Products, Services and Solutions
5.8.4 Glaxosmithkline HIV Vaccines Revenue (US$ Million) & (2024-2024)
5.8.5 Glaxosmithkline Recent Developments
5.9 Sanofi
5.9.1 Sanofi Profile
5.9.2 Sanofi Main Business
5.9.3 Sanofi HIV Vaccines Products, Services and Solutions
5.9.4 Sanofi HIV Vaccines Revenue (US$ Million) & (2024-2024)
5.9.5 Sanofi Recent Developments
6 North America
6.1 North America HIV Vaccines Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe HIV Vaccines Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific HIV Vaccines Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America HIV Vaccines Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa HIV Vaccines Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 HIV Vaccines Market Dynamics
11.1 HIV Vaccines Industry Trends
11.2 HIV Vaccines Market Drivers
11.3 HIV Vaccines Market Challenges
11.4 HIV Vaccines Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market HIV Vaccines Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global HIV Vaccines Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global HIV Vaccines Market Size Share by Region (2024-2024)
Table 4. Global HIV Vaccines Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global HIV Vaccines Forecasted Market Size Share by Region (2024-2034)
Table 6. Global HIV Vaccines Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global HIV Vaccines Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global HIV Vaccines Revenue Market Share by Type (2024-2024)
Table 9. Global HIV Vaccines Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global HIV Vaccines Revenue Market Share by Type (2024-2034)
Table 11. North America HIV Vaccines Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America HIV Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe HIV Vaccines Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe HIV Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific HIV Vaccines Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific HIV Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America HIV Vaccines Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America HIV Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa HIV Vaccines Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa HIV Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global HIV Vaccines Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global HIV Vaccines Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global HIV Vaccines Revenue Market Share by Application (2024-2024)
Table 24. Global HIV Vaccines Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global HIV Vaccines Revenue Market Share by Application (2024-2034)
Table 26. North America HIV Vaccines Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America HIV Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe HIV Vaccines Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe HIV Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific HIV Vaccines Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific HIV Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America HIV Vaccines Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America HIV Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa HIV Vaccines Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa HIV Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global HIV Vaccines Revenue (US$ Million) by Players (2024-2024)
Table 37. Global HIV Vaccines Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HIV Vaccines as of 2022)
Table 39. Date of Key Players Enter into HIV Vaccines Market
Table 40. Global HIV Vaccines Key Players Headquarters and Area Served
Table 41. HIV Vaccines Product Solution and Service
Table 42. Global HIV Vaccines Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Argos Therapeutics Basic Information List
Table 45. Argos Therapeutics Description and Business Overview
Table 46. Argos Therapeutics HIV Vaccines Products, Services and Solutions
Table 47. Revenue (US$ Million) in HIV Vaccines Business of Argos Therapeutics (2024-2024)
Table 48. Argos Therapeutics Recent Developments
Table 49. Bionor Pharma Basic Information List
Table 50. Bionor Pharma Description and Business Overview
Table 51. Bionor Pharma HIV Vaccines Products, Services and Solutions
Table 52. Revenue (US$ Million) in HIV Vaccines Business of Bionor Pharma (2024-2024)
Table 53. Bionor Pharma Recent Developments
Table 54. Janssen Global Services Basic Information List
Table 55. Janssen Global Services Description and Business Overview
Table 56. Janssen Global Services HIV Vaccines Products, Services and Solutions
Table 57. Revenue (US$ Million) in HIV Vaccines Business of Janssen Global Services (2024-2024)
Table 58. Janssen Global Services Recent Developments
Table 59. Genecure Basic Information List
Table 60. Genecure Description and Business Overview
Table 61. Genecure HIV Vaccines Products, Services and Solutions
Table 62. Revenue (US$ Million) in HIV Vaccines Business of Genecure (2024-2024)
Table 63. Genecure Recent Developments
Table 64. Geovax Basic Information List
Table 65. Geovax Description and Business Overview
Table 66. Geovax HIV Vaccines Products, Services and Solutions
Table 67. Revenue (US$ Million) in HIV Vaccines Business of Geovax (2024-2024)
Table 68. Geovax Recent Developments
Table 69. Paxvax Basic Information List
Table 70. Paxvax Description and Business Overview
Table 71. Paxvax HIV Vaccines Products, Services and Solutions
Table 72. Revenue (US$ Million) in HIV Vaccines Business of Paxvax (2024-2024)
Table 73. Paxvax Recent Developments
Table 74. Inovio Pharmaceuticals Basic Information List
Table 75. Inovio Pharmaceuticals Description and Business Overview
Table 76. Inovio Pharmaceuticals HIV Vaccines Products, Services and Solutions
Table 77. Revenue (US$ Million) in HIV Vaccines Business of Inovio Pharmaceuticals (2024-2024)
Table 78. Inovio Pharmaceuticals Recent Developments
Table 79. Glaxosmithkline Basic Information List
Table 80. Glaxosmithkline Description and Business Overview
Table 81. Glaxosmithkline HIV Vaccines Products, Services and Solutions
Table 82. Revenue (US$ Million) in HIV Vaccines Business of Glaxosmithkline (2024-2024)
Table 83. Glaxosmithkline Recent Developments
Table 84. Sanofi Basic Information List
Table 85. Sanofi Description and Business Overview
Table 86. Sanofi HIV Vaccines Products, Services and Solutions
Table 87. Revenue (US$ Million) in HIV Vaccines Business of Sanofi (2024-2024)
Table 88. Sanofi Recent Developments
Table 89. North America HIV Vaccines Market Size by Country (2024-2024) & (US$ Million)
Table 90. North America HIV Vaccines Market Size by Country (2024-2034) & (US$ Million)
Table 91. Europe HIV Vaccines Market Size by Country (2024-2024) & (US$ Million)
Table 92. Europe HIV Vaccines Market Size by Country (2024-2034) & (US$ Million)
Table 93. Asia-Pacific HIV Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 94. Asia-Pacific HIV Vaccines Market Size by Region (2024-2024) & (US$ Million)
Table 95. Asia-Pacific HIV Vaccines Market Size by Region (2024-2034) & (US$ Million)
Table 96. Asia-Pacific HIV Vaccines Market Share by Region (2024-2024)
Table 97. Asia-Pacific HIV Vaccines Market Share by Region (2024-2034)
Table 98. Latin America HIV Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 99. Latin America HIV Vaccines Market Size by Country (2024-2024) & (US$ Million)
Table 100. Latin America HIV Vaccines Market Size by Country (2024-2034) & (US$ Million)
Table 101. Middle East & Africa HIV Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 102. Middle East & Africa HIV Vaccines Market Size by Country (2024-2024) & (US$ Million)
Table 103. Middle East & Africa HIV Vaccines Market Size by Country (2024-2034) & (US$ Million)
Table 104. HIV Vaccines Market Trends
Table 105. HIV Vaccines Market Drivers
Table 106. HIV Vaccines Market Challenges
Table 107. HIV Vaccines Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HIV Vaccines Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global HIV Vaccines Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global HIV Vaccines Market Share by Regions: 2022 VS 2034
Figure 4. Global HIV Vaccines Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America HIV Vaccines Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe HIV Vaccines Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific HIV Vaccines Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America HIV Vaccines Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa HIV Vaccines Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Phase I
Figure 11. Global Phase I Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Phase II
Figure 13. Global Phase II Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Phase III
Figure 15. Global Phase III Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Global HIV Vaccines Market Size Share by Type: 2022 & 2034
Figure 17. North America HIV Vaccines Revenue Market Share by Type (2024-2034)
Figure 18. Europe HIV Vaccines Revenue Market Share by Type (2024-2034)
Figure 19. Asia-Pacific HIV Vaccines Revenue Market Share by Type (2024-2034)
Figure 20. Latin America HIV Vaccines Revenue Market Share by Type (2024-2034)
Figure 21. Middle East and Africa HIV Vaccines Revenue Market Share by Type (2024-2034)
Figure 22. Research Institute Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Global HIV Vaccines Market Size Share by Application: 2022 & 2034
Figure 25. North America HIV Vaccines Revenue Market Share by Application (2024-2034)
Figure 26. Europe HIV Vaccines Revenue Market Share by Application (2024-2034)
Figure 27. Asia-Pacific HIV Vaccines Revenue Market Share by Application (2024-2034)
Figure 28. Latin America HIV Vaccines Revenue Market Share by Application (2024-2034)
Figure 29. Middle East and Africa HIV Vaccines Revenue Market Share by Application (2024-2034)
Figure 30. HIV Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 31. Global Top 5 and Top 10 Players HIV Vaccines Market Share in 2022
Figure 32. North America HIV Vaccines Market Share by Country (2024-2034)
Figure 33. U.S. HIV Vaccines Market Size (2024-2034) & (US$ Million)
Figure 34. Canada HIV Vaccines Market Size (2024-2034) & (US$ Million)
Figure 35. Germany HIV Vaccines Market Size (2024-2034) & (US$ Million)
Figure 36. France HIV Vaccines Market Size (2024-2034) & (US$ Million)
Figure 37. U.K. HIV Vaccines Market Size (2024-2034) & (US$ Million)
Figure 38. Italy HIV Vaccines Market Size (2024-2034) & (US$ Million)
Figure 39. Russia HIV Vaccines Market Size (2024-2034) & (US$ Million)
Figure 40. Nordic Countries HIV Vaccines Market Size (2024-2034) & (US$ Million)
Figure 41. Asia-Pacific HIV Vaccines Market Share by Region (2024-2034)
Figure 42. China HIV Vaccines Market Size (2024-2034) & (US$ Million)
Figure 43. Japan HIV Vaccines Market Size (2024-2034) & (US$ Million)
Figure 44. South Korea HIV Vaccines Market Size (2024-2034) & (US$ Million)
Figure 45. Southeast Asia HIV Vaccines Market Size (2024-2034) & (US$ Million)
Figure 46. India HIV Vaccines Market Size (2024-2034) & (US$ Million)
Figure 47. Australia HIV Vaccines Market Size (2024-2034) & (US$ Million)
Figure 48. Latin America HIV Vaccines Market Share by Country (2024-2034)
Figure 49. Mexico HIV Vaccines Market Size (2024-2034) & (US$ Million)
Figure 50. Brazil HIV Vaccines Market Size (2024-2034) & (US$ Million)
Figure 51. Middle East & Africa HIV Vaccines Market Share by Country (2024-2034)
Figure 52. Turkey HIV Vaccines Market Size (2024-2034) & (US$ Million)
Figure 53. Saudi Arabia HIV Vaccines Market Size (2024-2034) & (US$ Million)
Figure 54. UAE HIV Vaccines Market Size (2024-2034) & (US$ Million)
Figure 55. Bottom-up and Top-down Approaches for This Report